You cannot register for this webinar

Please join PPMD and Capricor Therapeutics for a community webinar on Thursday, March 6, 2025 at 1:00PM ET. The Capricor team will provide a current update on the company’s Biologics License Application (BLA) seeking full approval of deramiocel (CAP-1002), Capricor’s novel cell therapy for the treatment of cardiomyopathy in patients diagnosed with Duchenne. Please submit questions in advance: https://forms.gle/8FG5YUZZ4nBTiP7L9